Suppr超能文献

MTA2表达水平与结直肠癌之间的预后相关性

Prognostic correlation between MTA2 expression level and colorectal cancer.

作者信息

Ding Weijun, Hu Wei, Yang Haihua, Ying Ting, Tian Ye

机构信息

Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University Suzhou 215004, China ; Department of Radiotherapy and Oncology, The Affiliated Taizhou Hospital of Wenzhou Medical University Taizhou 317000, China.

Department of Radiotherapy and Oncology, The Affiliated Taizhou Hospital of Wenzhou Medical University Taizhou 317000, China.

出版信息

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7173-80. eCollection 2015.

Abstract

OBJECTIVES

Association of MTA2 expression with presence, development, metastasis and prognosis of colorectal cancer (CRC) was investigated.

METHODS

90 CRC-related cases with follow-up information were made into tissue microarrays according to the paired principle of cancer tissues and the adjacent tissues. Subsequently, the expression of MAT2 was detected with immunohistochemical analysis and SPSS software was finally utilized to analyze the relationships between experimental data and clinical indicatives.

RESULTS

Expression of MTA2 in CRC tissues were notably higher than their adjacent tissues (P < 0.001) and showed significant positive correlation with tumor grade (r(2) > 0, P < 0.01). Moreover, survival analysis indicated that MTA2 expression in cancer tissues, serving as an independent correlation factor, was significantly correlated with poor prognosis (P = 0.004).

CONCLUSIONS

MTA2 is a crucial biomarker that is closely related with prognosis of CRC and also a potential molecular target for evaluating the prognosis and treatment of CRC.

摘要

目的

研究MTA2表达与结直肠癌(CRC)的发生、发展、转移及预后的关系。

方法

根据癌组织与癌旁组织配对原则,将90例有随访信息的CRC相关病例制成组织芯片。随后,采用免疫组化分析检测MAT2的表达,最后利用SPSS软件分析实验数据与临床指标之间的关系。

结果

CRC组织中MTA2的表达明显高于其癌旁组织(P < 0.001),且与肿瘤分级呈显著正相关(r(2)>0,P < 0.01)。此外,生存分析表明,癌组织中MTA2的表达作为一个独立的相关因素,与预后不良显著相关(P = 0.004)。

结论

MTA2是一个与CRC预后密切相关的关键生物标志物,也是评估CRC预后和治疗的潜在分子靶点。

相似文献

1
Prognostic correlation between MTA2 expression level and colorectal cancer.
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7173-80. eCollection 2015.
2
Expression of MTA2 and Ki-67 in hepatocellular carcinoma and their correlation with prognosis.
Int J Clin Exp Pathol. 2015 Oct 1;8(10):13083-9. eCollection 2015.
3
CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Hum Pathol. 2016 Apr;50:101-8. doi: 10.1016/j.humpath.2015.11.008. Epub 2015 Nov 28.
4
5
Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11393-9. eCollection 2015.
7
High Rab27A expression indicates favorable prognosis in CRC.
Diagn Pathol. 2015 Jun 13;10:68. doi: 10.1186/s13000-015-0303-3.
8
Overexpression of metastasis-associated protein 2 is associated with hepatocellular carcinoma size and differentiation.
J Gastroenterol Hepatol. 2009 Aug;24(8):1445-50. doi: 10.1111/j.1440-1746.2009.05965.x.
10

引用本文的文献

2
Emerging role for R-loop formation in hepatocellular carcinoma.
Genes Genomics. 2023 May;45(5):543-551. doi: 10.1007/s13258-022-01360-8. Epub 2023 Jan 12.
3
MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop.
Cancer Sci. 2021 Mar;112(3):1060-1074. doi: 10.1111/cas.14778. Epub 2021 Jan 19.
4
Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer.
Mol Ther Nucleic Acids. 2020 Jun 5;20:699-710. doi: 10.1016/j.omtn.2020.04.009. Epub 2020 Apr 28.
10
Metastasis-associated protein 3 in colorectal cancer determines tumor recurrence and prognosis.
Oncotarget. 2017 Jun 6;8(23):37164-37171. doi: 10.18632/oncotarget.16332.

本文引用的文献

1
Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer.
PLoS One. 2014 Mar 3;9(3):e90810. doi: 10.1371/journal.pone.0090810. eCollection 2014.
2
Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1.
Cancer Res. 2014 Mar 1;74(5):1484-94. doi: 10.1158/0008-5472.CAN-13-2020. Epub 2014 Jan 10.
3
Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer.
Breast Cancer Res Treat. 2013 Oct;141(3):375-384. doi: 10.1007/s10549-013-2709-5. Epub 2013 Sep 28.
4
MTA2 expression is a novel prognostic marker for pancreatic ductal adenocarcinoma.
Tumour Biol. 2013 Jun;34(3):1553-7. doi: 10.1007/s13277-013-0685-3. Epub 2013 Feb 12.
6
Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer.
Target Oncol. 2012 Jun;7(2):135-43. doi: 10.1007/s11523-012-0215-z. Epub 2012 May 15.
7
Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer.
Cancer Res. 2012 Jan 15;72(2):387-94. doi: 10.1158/0008-5472.CAN-11-2345.
8
Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.
J Natl Cancer Inst. 2011 Apr 6;103(7):538-52. doi: 10.1093/jnci/djr058. Epub 2011 Mar 29.
9
Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis.
Cancer Res. 2011 Jan 1;71(1):245-54. doi: 10.1158/0008-5472.CAN-10-2330.
10
Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity.
Cytoskeleton (Hoboken). 2010 Sep;67(9):545-54. doi: 10.1002/cm.20472.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验